Cellular and Molecular Mechanisms of Inhibin Action on the Skeleton

抑制素对骨骼作用的细胞和分子机制

• 批准号: 7409819
• 负责人: Kristy M Nicks
• 金额: $ 2.84万
• 依托单位: UNIV OF ARKANSAS FOR MED SCIS
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-03-01 至 2011-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7409819
• 关键词: Aging; BMP5 gene; Cultured Cells; Disease; Genes; Immunohistochemistry; In Vitro; Inhibin A; Insulin-Like Growth Factor I; Mediating; Methodology; Methods; Molecular; Molecular Profiling; Mus; One-Step dentin bonding system; Osteogenesis; Osteoporosis; Polymerase Chain Reaction; Purpose; Regulation; Skeleton; Time; VEGFA gene; Woman; base; bone; bone loss; bone metabolism; bone turnover; gonad function; in vivo; inhibin; men; novel; research study

DESCRIPTION (provided by applicant): The purpose of this proposal is to identify the cellular and mechanistic actions of Inhibin as it involves bone formation. The focus of this proposal is to determine the molecular mechanisms by which Inhibins exert a bimodal regulation on the skeleton such that short-term exposure represses osteoblastogenesis and long-term continuous exposure stimulates bone formation. The approach will be to determine the cellular basis of the bimodal regulation of Inhibin A on bone turnover in vivo, and then to validate the involvement of three specific genes identified in expression profiling, IGF-1, VEGFA and BMP5 with IGF-1 the priority, to determine their involvement in Inhibin A-regulated bone metabolism. This will be specifically performed by, AIM1: Determining the effects of Inhibin A on the cellular composition of bone and bone turnover across a time course of continuous Inhibin A exposure. AIM 2: Determining the extent to which Inhibin A regulates IGF-1 in vitro and in vivo to alter osteoblastogenesis and bone formation. AIM 3: Determining if the effects of Inhibin A on bone metabolism are mediated by changes in IGF-1, and whether IGF-1 mediates Inhibin A action on the skeleton. The methods involved will include RT and real time PCR, immunoneutralization experiments, static and dynamic histomorphometry, immunohistochemistry and cell cultures. This proposal is a novel and beneficial idea to the bone field. Osteoporosis is a disease that has become a prevalent problem in both men and women. A primary cause of bone loss is loss of gonadal function associated with aging. Recent identification of the anabolic action of Inhibins on bone brings the field one step closer to finding another possible treatment. However, the action is not known. This proposal seeks to identify those mechanisms of action.

描述（由申请人提供）：本提案的目的是确定抑制素的细胞和机制作用，因为它涉及骨形成。本提案的重点是确定抑制素对骨骼发挥双峰调节的分子机制，即短期暴露抑制成骨细胞发生，长期持续暴露刺激骨形成。该方法将确定抑制素A在体内对骨转换的双峰调节的细胞基础，然后验证在表达谱中鉴定的三个特定基因，IGF-1， VEGFA和BMP5 （IGF-1优先）的参与，以确定它们参与抑制素A调节的骨代谢。这将具体由AIM1：确定抑制素A在持续暴露于抑制素A的一段时间内对骨细胞组成和骨转换的影响。目的2：确定抑制素A在体外和体内调节IGF-1改变成骨细胞发生和骨形成的程度。目的3：确定抑制素A对骨代谢的影响是否通过IGF-1的改变介导，以及IGF-1是否介导抑制素A对骨骼的作用。所涉及的方法将包括RT和实时PCR，免疫中和实验，静态和动态组织形态学，免疫组织化学和细胞培养。这对骨领域来说是一个新颖而有益的想法。骨质疏松症是一种普遍存在于男性和女性中的疾病。骨质流失的一个主要原因是与衰老有关的性腺功能的丧失。最近对抑制素对骨的合成代谢作用的鉴定使该领域更接近于找到另一种可能的治疗方法。然而，其作用尚不清楚。本建议旨在确定这些行动机制。